SANOFI US SERVICES INC. for SANOFI US SERVICES INC
What was lobbied
8 issue areas, each in the filer's own words, with who lobbied on it and where.
Copyright/Patent/Trademark CPT
International intellectual property issues; general issues related to patent settlements; and all provisions of HR9 "The Innovation Act"
Foreign entity interest: Sanofi US Services Inc. is owned by Sanofi SA and to the degree that public policies, either laws or regulations, commercially benefit Sanofi US Services Inc., so too Sanofi SA, as the parent corporation, will benefit.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ALISON CARA BONEBRAKE | — |
| SEAN CALLINICOS | — |
| MARYANNE DOLBEARE DUNLAP | — |
| PATRICK MAYES MCLAIN | — |
| AMY L REDL | — |
Pharmacy PHA
General issues related to the 340B Federal Drug Pricing Program
Foreign entity interest: Sanofi US Services Inc. is owned by Sanofi SA and to the degree that public policies, either laws or regulations, commercially benefit Sanofi US Services Inc., so too Sanofi SA, as the parent corporation, will benefit.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ALISON CARA BONEBRAKE | — |
| SEAN CALLINICOS | — |
| PATRICK MAYES MCLAIN | — |
| AMY L REDL | — |
Trade (domestic/foreign) TRD
General issues related to Trade Promotion Authority (TPA), Trans-Pacific Partnership (TPP) negotiations, and Trans Atlantic Trade and Investment Partnership (TTIP) negotiations
Foreign entity interest: Sanofi US Services Inc. is owned by Sanofi SA and to the degree that public policies, either laws or regulations, commercially benefit Sanofi US Services Inc., so too Sanofi SA, as the parent corporation, will benefit.
| Lobbyist | Covered position, as disclosed |
|---|---|
| SEAN CALLINICOS | — |
| PATRICK MAYES MCLAIN | — |
Taxation/Internal Revenue Code TAX
Corporate tax reform; a strengthened and permanent U.S. R&D tax credit, including all provisions of HR880 "American Research and Competitiveness Act of 2015"; and all provisions of HR1270 and S709 "Restoring Access to Medication Act of 2015"
Foreign entity interest: Sanofi US Services Inc. is owned by Sanofi SA and to the degree that public policies, either laws or regulations, commercially benefit Sanofi US Services Inc., so too Sanofi SA, as the parent corporation, will benefit.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ALISON CARA BONEBRAKE | — |
| MARYANNE DOLBEARE DUNLAP | — |
| PATRICK MAYES MCLAIN | — |
| AMY L REDL | — |
| ANN TAYLOR | — |
Economics/Economic Development ECN
General issues related to the importance of foreign direct investment in the U.S.
Foreign entity interest: Sanofi SA, the foreign parent corporation of Sanofi US Services Inc. invests in its business in the U.S.
| Lobbyist | Covered position, as disclosed |
|---|---|
| PATRICK MAYES MCLAIN | — |
| ANN TAYLOR | — |
Health Issues HCR
Education and awareness of the 2014-2015 influenza season; education and awareness of pandemic and biodefense funding; education and awareness of Dengue; general issues related to FDA and NIH funding; all provisions of S320 and HR744 "Medical Innovation Act"; the importance of immunizations for herd immunity; all issues related to the 21st Century Cures Initiative; general issues related to the importation of pharmaceutical products, including all provisions of S122 "Safe and Affordable Drugs from Canada Act of 2015; all provisions of Preserving Access to Orphan Drugs Act (discussion draft); The President's Budget Proposal - the proposal related to reducing from 12 years to 7 years the data exclusivity period for innovator biologics and the proposal related to generating additional savings from the Independent Payment Advisory Board (IPAB); education and awareness of diabetes and related treatments; OTC-HSA; general issues related to awareness of Ebola; and education and awareness of cardiovascular disease and related treatments.
Foreign entity interest: Sanofi US Services Inc. is owned by Sanofi SA and to the degree that public policies, either laws or regulations, commercially benefit Sanofi US Services Inc., so too Sanofi SA, as the parent corporation, will benefit.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ALISON CARA BONEBRAKE | — |
| SEAN CALLINICOS | — |
| MARYANNE DOLBEARE DUNLAP | — |
| PATRICK MAYES MCLAIN | — |
| AMY L REDL | — |
| ANN TAYLOR | — |
Medicare/Medicaid MMM
Issues related to the Medicaid rebate policy; general issues related to the Medicare Part D program; coverage and reimbursement for the Medicare Part D prescription drug benefit and all provisions of S31 "Medicare Prescription Drug Price Negotiation Act"; general issues related to the Medicare Part B reimbursement of prescription drugs; proposals set forth in the President's Budget Request relating to applying a Medicaid rebate to Medicare Part D for low income subsidy beneficiaries, increasing the manufacturer Part D coverage gap discounts for brand name drugs, repealing the non-interference provision, restructuring generic and brand copayments for low income subsidy beneficiaries, and reducing reimbursement for Medicare Part B medicines; and all provisions of HR2 "Medicare Access and CHIP Reauthorization Act of 2015"
Foreign entity interest: Sanofi US Services Inc. is owned by Sanofi SA and to the degree that public policies, either laws or regulations, commercially benefit Sanofi US Services Inc., so too Sanofi SA, as the parent corporation, will benefit.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ALISON CARA BONEBRAKE | — |
| SEAN CALLINICOS | — |
| MARYANNE DOLBEARE DUNLAP | — |
| PATRICK MAYES MCLAIN | — |
| AMY L REDL | — |
| ANN TAYLOR | — |
Animals ANI
Education and awareness about the Oral Rabies Vaccine Program
Foreign entity interest: Sanofi US Services Inc. is owned by Sanofi SA and to the degree that public policies, either laws or regulations, commercially benefit Sanofi US Services Inc., so too Sanofi SA, as the parent corporation, will benefit.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MARYANNE DOLBEARE DUNLAP | — |
| PATRICK MAYES MCLAIN | — |
Affiliated organisations
| Organisation | Location |
|---|---|
| CHATTEM, INC. | Chattanooga, TN, US |
| SANOFI PASTEUR | Swiftwater, PA, US |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.